- Trials with a EudraCT protocol (6)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
6 result(s) found for: APDS.
Displaying page 1 of 1.
EudraCT Number: 2015-002900-10 | Sponsor Protocol Number: APD001 | Start Date*: 2016-01-29 |
Sponsor Name:UCB Celltech, UK Registered Branch of UCB Pharma SA | ||
Full Title: AN OPEN-LABEL EXPLORATORY STUDY OF UCB5857 IN SUBJECTS WITH ACTIVATED PHOSPHOINOSITIDE 3 KINASE (PI3K) DELTA SYNDROME (APDS) | ||
Medical condition: Activated PI3K delta Syndrome (APDS) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: IT (Completed) DE (Completed) ES (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000468-41 | Sponsor Protocol Number: CCDZ173X2201E1 | Start Date*: 2016-07-19 | |||||||||||
Sponsor Name:Pharming Technologies B.V. | |||||||||||||
Full Title: An open-label, non-randomized extension study to evaluate the long term safety, tolerability, efficacy and pharmacokinetics of CDZ173 (leniolisib) in patients with APDS/PASLI (Activated phosphoinos... | |||||||||||||
Medical condition: APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) NL (Ongoing) IE (Completed) GB (GB - no longer in EU/EEA) FR (Completed) DE (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003876-22 | Sponsor Protocol Number: CCDZ173X2201 | Start Date*: Information not available in EudraCT |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: An open-label, non-randomized, within-patient dose-finding study followed by a randomized, subject, investigator and sponsor-blinded placebo controlled study to assess the efficacy and safety of CD... | ||
Medical condition: APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/ p110δ-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) CZ (Completed) NL (Completed) IE (Completed) FR (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004876-31 | Sponsor Protocol Number: 204745 | Start Date*: 2016-03-28 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: An open-label, single arm study to investigate the safety, pharmacokinetics and pharmacodynamics of repeat doses of inhaled nemiralisib in patients with APDS/PASLI | |||||||||||||
Medical condition: patients with APDS/PASLI | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005541-30 | Sponsor Protocol Number: APD003 | Start Date*: 2016-08-23 |
Sponsor Name:UCB BioPharma SPRL | ||
Full Title: AN OPEN-LABEL, EXPLORATORY, MULTICENTER, EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF UCB5857 IN SUBJECTS WITH ACTIVATED PHOSPHOINOSITIDE 3 KINAS... | ||
Medical condition: Activated PI3K delta Syndrome (APDS) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) IT (Completed) ES (Prematurely Ended) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001624-14 | Sponsor Protocol Number: LE3301 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Pharming Technologies B.V. | |||||||||||||
Full Title: An Open-Label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Leniolisib in Pediatric Patients (Aged 4 to 11 Years) With APDS (Activated Phosphoinositide 3-Kina... | |||||||||||||
Medical condition: Activated Phosphoinositide 3-Kinase Delta Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.